CTOs on the Move

IconOVir

www.iconovir.com

 
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O`Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.iconovir.com
  • 4570 Executive Drive Suite 350
    San Diego, CA USA 92121
  • Phone: n/a

Executives

Name Title Contact Details
John Huynh
 Chief Technology Officer Profile

Funding

IconOVir raised $77M on 01/05/2021

Similar Companies

ELEVAI Skincare

PharmaForm

PharmaForm is a leading specialty contract development and manufacturing organization focusing on oral and transmucosal dosage forms. Founded in 1996, PharmaForm has built a reputation for delivering novel and innovative solutions to challenging problems

William Gallagher Associates

William Gallagher Associates is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pharmative

Pharmative is a Northridge, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Iterion Therapeutics

Iterion Pharmaceuticals is a venture-backed, clinical stage biotechnology company developing novel targeted cancer therapeutics.